How to buy Theratechnologies stock (THTX)

Theratechnologies is a biotechnology business based in the US. Theratechnologies shares (THTX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.83 – an increase of 2.23% over the previous week. Theratechnologies employs 103 staff and has a trailing 12-month revenue of around $84.3 million.

Our top picks for where to buy Theratechnologies stock

Buy Theratechnologies stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Theratechnologies stock price (NASDAQ: THTX)

Use our graph to track the performance of THTX stocks over time.

Theratechnologies shares at a glance

• Key figures

Information last updated 2024-12-26.

Latest market close	$1.83
52-week range	$1.08 - $2.58
50-day moving average more info button	$1.35
200-day moving average more info button	$1.33
Wall St. target price	$3.79
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.04

Is it a good time to buy Theratechnologies stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Theratechnologies price performance over time

Historical closes compared with the close of $1.8262 from 2024-12-24

1 week (2024-12-20)	2.02%
1 month (2024-11-27)	54.76%
3 months (2024-09-27)	46.10%
6 months (2024-06-27)	31.38%

1 year (2023-12-27)	14.14%
2 years (2022-12-27)	-50.38%
3 years (2021-12-27)	11.8
5 years (2019-12-27)	11.92

Is Theratechnologies stock undervalued or overvalued?

Valuing Theratechnologies stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Theratechnologies's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Theratechnologies's EBITDA

Theratechnologies's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $14.4 million.

The EBITDA is a measure of a Theratechnologies's overall financial performance and is widely used to measure a its profitability.

Theratechnologies financials

Revenue TTM	$84.3 million
Operating margin TTM	27.49%
Gross profit TTM	$56.2 million
Return on assets TTM	11.76%
Return on equity TTM	-1116.86%
Profit margin	-3.75%
Book value	$-0.43
Market Capitalization more info button	$84 million

TTM: trailing 12 months

Theratechnologies share dividends

We're not expecting Theratechnologies to pay a dividend over the next 12 months.

Have Theratechnologies's shares ever split?

Theratechnologies's shares were split on a 1:4 basis on 30 July 2023 . So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Theratechnologies shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Theratechnologies shares which in turn could have impacted Theratechnologies's share price.

Theratechnologies share price volatility

Over the last 12 months, Theratechnologies's shares have ranged in value from as little as $1.08 up to $2.58. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Theratechnologies's is 1.725. This would suggest that Theratechnologies's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Theratechnologies overview

Theratechnologies Inc. , a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen. Its pipeline products include F8 Formulation that is in Phase 2b/3 clinical trials for studying tesamorelin for the treatment of nonalcoholic steatohepatitis; multi -dose pen injector for the administration of tesamorelin; SORT1+ Technology Platform for the development of proprietary peptides for cancer drug development targeting SORT1 receptors; Sudocetaxel Zendusortide, which is in Phase 1 Clinical Trial for various solid tumor types, including HR+ breast, triple negative breast, ovarian, endometrial, melanoma, thyroid, small cell lung, and prostate cancers. The company was incorporated in 1993 and is headquartered in Montreal, Canada. .

Frequently asked questions

What percentage of Theratechnologies is owned by insiders or institutions?
Currently 1.219% of Theratechnologies shares are held by insiders and 51.564% by institutions. How many people work for Theratechnologies?
Latest data suggests 103 work at Theratechnologies. When does the fiscal year end for Theratechnologies?
Theratechnologies's fiscal year ends in November. Where is Theratechnologies based?
Theratechnologies's address is: 2015 Peel Street, Montreal, QC, Canada, H3A 1T8 What is Theratechnologies's ISIN number?
Theratechnologies's international securities identification number is: CA88338H1001 What is Theratechnologies's CUSIP number?
Theratechnologies's Committee on Uniform Securities Identification Procedures number is: 88338H100